TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CLDX

Celldex Therapeutics Inc

Healthcare · Biotechnology

38.20$ -1.9% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Celldex Therapeutics Inc (CLDX): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/09/2026.

Next report 11/09/2026
Last report 08/06/2026
Earnings surprise by quarter (%)
Q3 23 · -22.7 % 23 Q4 23 · -12.2 % 23 Q1 24 · 16.4 % 24 Q2 24 · 8.5 % 24 Q3 24 · 4.5 % 24 Q4 24 · 0.6 % 24 Q1 25 · -9.5 % 25 Q2 25 · 1.2 % 25 Q3 25 · -13.5 % 25 Q4 25 · -22.0 % 25 Q1 26 · -4.4 % 26 Q2 26 · 9.6 % 26

EPS estimate beaten

Full history 59 of 114 quarters (52%)
Last 16 quarters 8 of 16 quarters (50%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/06/2026 Celldex Therapeutics, Inc. (CLDX): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/15/2026 Celldex Therapeutics, Inc. (CLDX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?